RadNet, Inc.
RDNT
Kedudukan dalam Saham
#3240
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Harga Saham
$69.56
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$5.47B
Perubahan (1 hari)
1.10%
Perubahan (1 tahun)
-11.33%
Negara
US
Perdagangan RadNet, Inc. (RDNT)
Kategori
Healthcare
Nisbah P/E bagi RadNet, Inc. (RDNT)
Nisbah P/E pada October 2026 TTM: -259.51
Menurut laporan kewangan dan harga saham terkini RadNet, Inc., nisbah P/E semasa (TTM) ialah -259.51. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak 726.24.
Sejarah nisbah P/E bagi RadNet, Inc. dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | -259.51 | -114.21% |
| 2024 | 1.83K | 151.48% |
| 2023 | 726.24 | 629.66% |
| 2022 | 99.53 | 55.70% |
| 2021 | 63.93 | -195.25% |
| 2020 | -67.11 | -256.00% |
| 2019 | 43.02 | 183.48% |
| 2018 | 15.18 | -99.83% |
| 2017 | 8.93K | 21,555.17% |
| 2016 | 41.26 | 17.48% |
| 2015 | 35.12 | -86.22% |
| 2014 | 254.90 | 726.72% |
| 2013 | 30.83 | 1,982.71% |
| 2012 | 1.48 | -86.55% |
| 2011 | 11.01 | -236.12% |
| 2010 | -8.09 | -75.07% |
| 2009 | -32.44 | 247.95% |
| 2008 | -9.32 | -51.86% |
| 2007 | -19.37 | 23.60% |
| 2006 | -15.67 | 222.14% |
| 2005 | -4.86 | 203.93% |
| 2004 | -1.60 | -80.41% |
| 2003 | -8.17 | 38.63% |
| 2002 | -5.89 | -325.02% |
| 2001 | 2.62 | -61.00% |
| 2000 | 6.71 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 36.15 | -113.93% |
US
|
|
| 39.77 | -115.33% |
US
|
|
| -290.26 | 11.85% |
US
|
|
| - | - |
CN
|
|
| 34.18 | -113.17% |
US
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.